Versartis Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting

SAN FRANCISCO, CA -- (Marketwired) -- 06/16/13 -- Versartis, Inc. today presented the first results from…

Continue Reading